Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Nachury

Showing results (41-50 of 96) with videos related to

Pageof 10
Sort By:
Inflammatory Bowel Diseases|January 31, 2022
INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn's Disease Treated in the ADMIRE-CD TrialJulian Panés, Gerd Bouma, Marc Ferrante, et al.
Alimentary Pharmacology & Therapeutics|June 21, 2021
Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis: A GETAID cohortMathieu Uzzan, Clément Bresteau, David Laharie, et al.
Journal of Crohn'S & Colitis|September 20, 2022
Comparison of the Risk of Crohn's Disease Postoperative Recurrence Between Modified Rutgeerts Score i2a and i2b Categories: An Individual Patient Data Meta-analysisPauline Rivière, Joel Pekow, Nassim Hammoudi, et al.
Cancers|April 13, 2023
Preoperative Predictors of Neoplasia in Patients Undergoing Small Bowel Resection for Complicated Crohn's Disease: A Multicentre Case-Control StudyCapucine Chappe, Cecile Salut, Aurelien Amiot, et al.
Journal of Crohn'S & Colitis|October 5, 2023
Tofacitinib for Patients with Anti-TNF Refractory Ulcerative Proctitis: A Multicentre Cohort Study from the GETAIDMathieu Uzzan, Maria Nachury, Alexandre Nuzzo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 16, 2018
Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case seriesRomain Altwegg, Roman Combes, David Laharie, et al.
Lancet (London, England)|August 2, 2016
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trialJulián Panés, Damián García-Olmo, Gert Van Assche, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2025
Effectiveness and Safety of Upadacitinib Induction Therapy for 223 Patients With Crohn's Disease: A GETAID Multicentre Cohort StudyNicolas Richard, Aurélien Amiot, Philippe Seksik, et al.
Gut|April 1, 2022
Role of adherent and invasive <i>Escherichia coli</i> in Crohn's disease: lessons from the postoperative recurrence modelAnthony Buisson, Harry Sokol, Nassim Hammoudi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 29, 2021
Steroid-Free Deep Remission at One Year Does Not Prevent Crohn's Disease Progression: Long-Term Data From the TAILORIX TrialDavid Laharie, Geert D'Haens, Maria Nachury, et al.
Pageof 10

Showing results (41-50 of 96) with videos related to

Sort By:
Pageof 10
Inflammatory Bowel Diseases|January 31, 2022
INSPECT: A Retrospective Study to Evaluate Long-term Effectiveness and Safety of Darvadstrocel in Patients With Perianal Fistulizing Crohn's Disease Treated in the ADMIRE-CD TrialJulian Panés, Gerd Bouma, Marc Ferrante, et al.
Alimentary Pharmacology & Therapeutics|June 21, 2021
Tofacitinib as salvage therapy for 55 patients hospitalised with refractory severe ulcerative colitis: A GETAID cohortMathieu Uzzan, Clément Bresteau, David Laharie, et al.
Journal of Crohn'S & Colitis|September 20, 2022
Comparison of the Risk of Crohn's Disease Postoperative Recurrence Between Modified Rutgeerts Score i2a and i2b Categories: An Individual Patient Data Meta-analysisPauline Rivière, Joel Pekow, Nassim Hammoudi, et al.
Cancers|April 13, 2023
Preoperative Predictors of Neoplasia in Patients Undergoing Small Bowel Resection for Complicated Crohn's Disease: A Multicentre Case-Control StudyCapucine Chappe, Cecile Salut, Aurelien Amiot, et al.
Journal of Crohn'S & Colitis|October 5, 2023
Tofacitinib for Patients with Anti-TNF Refractory Ulcerative Proctitis: A Multicentre Cohort Study from the GETAIDMathieu Uzzan, Maria Nachury, Alexandre Nuzzo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|April 16, 2018
Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case seriesRomain Altwegg, Roman Combes, David Laharie, et al.
Lancet (London, England)|August 2, 2016
Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trialJulián Panés, Damián García-Olmo, Gert Van Assche, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2025
Effectiveness and Safety of Upadacitinib Induction Therapy for 223 Patients With Crohn's Disease: A GETAID Multicentre Cohort StudyNicolas Richard, Aurélien Amiot, Philippe Seksik, et al.
Gut|April 1, 2022
Role of adherent and invasive <i>Escherichia coli</i> in Crohn's disease: lessons from the postoperative recurrence modelAnthony Buisson, Harry Sokol, Nassim Hammoudi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 29, 2021
Steroid-Free Deep Remission at One Year Does Not Prevent Crohn's Disease Progression: Long-Term Data From the TAILORIX TrialDavid Laharie, Geert D'Haens, Maria Nachury, et al.
Pageof 10